Business Segments · Sales and marketing
Business Segments — Sales and marketing
Incyte Business Segments — Sales and marketing decreased by 15.9% to $259.56M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $257.65M to $259.56M. Over 3 years (FY 2022 to FY 2025), Business Segments — Sales and marketing shows an upward trend with a 12.4% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026Apr 28, 2026
Rolls up toSales & Marketing
How to read this metric
Rising costs should ideally correlate with revenue growth; if not, it may indicate diminishing returns on marketing spend.
Detailed definition
This reflects the investment in commercializing the company's drug portfolio, including sales force compensation, advert...
Peer comparison
Standard operating expense for all commercial-stage pharmaceutical companies.
Metric ID:
incy_segment_reportable_segment_sales_and_marketingHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $192.54M | $192.54M | $192.54M | $192.54M | $219.18M | $219.18M | $219.18M | $219.18M | $216.81M | $229.20M | $241.88M | $257.53M | $257.65M | $256.31M | $272.30M | $308.49M | $259.56M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +13.8% | +0.0% | +0.0% | +0.0% | -1.1% | +5.7% | +5.5% | +6.5% | +0.0% | -0.5% | +6.2% | +13.3% | -15.9% |
| YoY Change | — | — | — | — | +13.8% | +13.8% | +13.8% | +13.8% | -1.1% | +4.6% | +10.4% | +17.5% | +18.8% | +11.8% | +12.6% | +19.8% | +0.7% |
Range$192.54M – $308.49M
CAGR+7.8%
Avg YoY Growth+11.6%
Median YoY Growth+13.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's business segments — sales and marketing?
- Incyte (INCY) reported business segments — sales and marketing of $259.56M in Q1 2026.
- How has Incyte's business segments — sales and marketing changed year-over-year?
- Incyte's business segments — sales and marketing increased by 0.7% year-over-year, from $257.65M to $259.56M.
- What is the long-term trend for Incyte's business segments — sales and marketing?
- Over 3 years (2022 to 2025), Incyte's business segments — sales and marketing has grown at a 12.4% compound annual growth rate (CAGR), from $770.14M to $1.09B.
- What does business segments — sales and marketing mean?
- The total cost of promoting and selling the company's products.